Status:
RECRUITING
Usability of a Novel Cueing Device for Patients With Parkinson's Disease
Lead Sponsor:
Swiss Federal Institute of Technology
Collaborating Sponsors:
Rehaklinik Zihlschlacht AG
Conditions:
Freezing of Gait
Parkinson Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hypokinetic gait disorder and Freezing of Gait (FOG) are frequent symptoms in the advanced stage of Parkinson's disease (PD). These impair quality of life and significantly increase the risk of falls....
Eligibility Criteria
Inclusion
- Include patients who suffer from advanced PD. Characteristic symptoms of parkinsonian gait like hypokinetic movements and/or FOG have to be present.
- Parkinsonian gait is measured by the following items of the Movement Disorder Society Unified Parkinson Disease Rating Scale (MDS-UPDRS): item 2.12, item 2.13, item 3.10 and item 3.11. The Hoehn and Yahr (HY) stage during ON is 1-4/5.
- MoCA ≥ 22/30.
- Participant has signed the informed consent.
Exclusion
- Inability of the participant to understand the IC or to follow the procedures of the study (as judged by the Qualified Physician).
- Significantly, impaired cognitive skills render the participant unable to use the TCD.
- Presence of severe motor fluctuations and severely impaired walking ability as defined by HY stage V during ON.
- Clinically relevant skin lesions on the wrist or fixation points (usually the thighs).
Key Trial Info
Start Date :
November 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT04459559
Start Date
November 16 2020
End Date
December 31 2024
Last Update
January 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rehaklinik Zihlschlacht AG
Zihlschlacht, Thurgau, Switzerland, 8588